Company intelligence / Profile preview

Global X

New York, New York, United States

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Global X is a New York-based asset manager and sponsor of exchange-traded funds. The business develops and manages ETFs spanning thematic growth, income, commodities, international, core, and other investment strategies rather than therapeutics or healthcare products. It was founded in 2008 and operates as part of Mirae Asset Financial Group following its 2018 acquisition by Mirae Asset Global Investments. While some of its ETF products target healthcare-related themes such as genomics or health technology, Global X itself is a financial services company, not a biotech, pharma, or healthcare operating company.

Industry: Investors

Partnerships

Mirae Asset Financial GroupMirae Asset Global InvestmentsCboe Canada

Beyond the preview

Go deeper on Global X.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global X.

Explore the full profile